ArticleFrontiers in immunology2020

Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.

Rachel S Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.